ANTACID- magnesium oxide tablet 
Spirit Pharmaceuticals LLC

----------

Antacid

Drug Facts

Active Ingredient
(in each tablet)

Magnesium oxide 400 mg

(241.3 mg Elemental Magnesium)

Purpose

Antacid

Uses

relieves • acid indigestion • upset stomach

Warnings

Ask a doctor before use if you have

kidney disease

Ask a doctor or pharmacist before use if you are

taking a prescription drug. Antacids may interact with certain prescription drugs.

Do not take

more than 2 tablets in a 24 hour period or use the maximum dosage of this product for more than two weeks, except under the advise and under supervision of a physician. May have a laxative effect.

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

Directions

• take 1 tablet twice a day or as directed by physician

Other information

• Magnesium content per tablet: 240 mg
• store at controlled room temperature 15° to 30°C (59° to 86°F)

Inactive ingredients

Colloidal silicon dioxide, croscarmellose sodium, microcrystalline cellulose, stearic acid

Questions or comments?

1-888-333-9792

Distributed by:

Cabinet Health P.B.C.

Principal Display

PACKAGE NOT CHILD-RESISTANT

CABINET

Antacid

Active ingredient:
MAGNESIUM OXIDE 400 MG
(241.3 MG ELEMENTAL MAGNESIUM)

Relieves:
Acid Indigestion
Upset Stomach

COMPOSTABLE REFILL POUCH

30 Tablets

1 x Magnetic Label

1 x Drug Facts Booklet

CABINET: The Sustainable Healthcare Co.™

Pouch

ANTACID 
magnesium oxide tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68210-4171
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
MAGNESIUM OXIDE (UNII: 3A3U0GI71G) (MAGNESIUM CATION - UNII:T6V3LHY838) MAGNESIUM CATION400 mg
Inactive Ingredients
Ingredient NameStrength
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
Product Characteristics
ColorwhiteScoreno score
ShapeROUNDSize11mm
FlavorImprint Code 174
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:68210-4171-330 in 1 POUCH; Type 0: Not a Combination Product11/16/2021
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00111/16/2021
Labeler - Spirit Pharmaceuticals LLC (179621011)

Revised: 12/2023
Document Id: 0befeb8e-e40d-0b7f-e063-6394a90aaa17
Set id: 1ad609ca-8108-4144-935d-0673013dbc1f
Version: 4
Effective Time: 20231207
 
Spirit Pharmaceuticals LLC